This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
Edgewell Personal Care (EPC) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Edgewell Personal (EPC) delivered earnings and revenue surprises of -8.91% and -4.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EPCNegative Net Change KVUENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of +88.24% and +24.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ESPRNegative Net Change NOTVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of +25.93% and +1.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LMNDNegative Net Change FNFNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ares Commercial Real Estate (ACRE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Ares Commercial Real Estate (ACRE) delivered earnings and revenue surprises of -2,450.00% and -16.06%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACRENegative Net Change RCNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates
by Zacks Equity Research
Amneal (AMRX) delivered earnings and revenue surprises of +38.89% and -0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AMRXNegative Net Change CATXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Clear Secure (YOU) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clear Secure (YOU) delivered earnings and revenue surprises of +13.04% and +2.09%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
YOUNegative Net Change INFAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Henry Schein (HSIC) Q2 Earnings Lag Estimates
by Zacks Equity Research
Henry Schein (HSIC) delivered earnings and revenue surprises of -6.78% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HSICNegative Net Change STAANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gartner (IT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Gartner (IT) delivered earnings and revenue surprises of +4.44% and +0.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ITNegative Net Change IIIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Leidos (LDOS) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Leidos (LDOS) delivered earnings and revenue surprises of +22.05% and +0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LDOSNegative Net Change CRNCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +26.19% and +0.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MDPositive Net Change NTRANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ball (BALL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ball (BALL) delivered earnings and revenue surprises of +3.45% and +5.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BALLNegative Net Change SSYSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of +5.66% and +1.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DDNegative Net Change KRONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
DHL Group Sponsored ADR (DHLGY) Q2 Earnings Beat Estimates
by Zacks Equity Research
DHL Group Sponsored ADR (DHLGY) delivered earnings and revenue surprises of +13.89% and -5.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DHLGYNegative Net Change AIOTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Yum China Holdings (YUMC) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Yum China (YUMC) delivered earnings and revenue surprises of +1.75% and +0.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
YUMCPositive Net Change JACKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Douglas Dynamics (PLOW) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Douglas Dynamics (PLOW) delivered earnings and revenue surprises of +35.71% and +3.97%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PLOWNegative Net Change KARNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Postal Realty Trust (PSTL) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Postal Realty Trust (PSTL) delivered FFO and revenue surprises of +10.00% and +3.84%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PSTLNegative Net Change AHRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Crescent Energy (CRGY) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Crescent Energy (CRGY) delivered earnings and revenue surprises of +86.96% and +0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CRGYNegative Net Change GEVOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MercadoLibre (MELI) Q2 Earnings Miss Estimates
by Zacks Equity Research
MercadoLibre (MELI) delivered earnings and revenue surprises of -14.15% and +4.10%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MELINegative Net Change CARSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Primoris Services (PRIM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Primoris Services (PRIM) delivered earnings and revenue surprises of +58.49% and +12.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PRIMPositive Net Change DYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Gladstone Capital (GLAD) Matches Q3 Earnings Estimates
by Zacks Equity Research
Gladstone Capital (GLAD) delivered earnings and revenue surprises of 0.00% and +0.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GLADNegative Net Change SCMNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
PLAYSTUDIOS, Inc. (MYPS) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
PLAYSTUDIOS (MYPS) delivered earnings and revenue surprises of -100.00% and -3.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MYPSPositive Net Change LNWPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BRC Inc. (BRCC) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
BRC INC (BRCC) delivered earnings and revenue surprises of -133.33% and +2.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BRCCPositive Net Change GONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LTC Properties (LTC) Q2 FFO Beat Estimates
by Zacks Equity Research
LTC (LTC) delivered FFO and revenue surprises of +1.49% and -7.81%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LTCNegative Net Change LAMRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
SES AI Corporation (SES) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
SES AI (SES) delivered earnings and revenue surprises of -40.00% and -21.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SESPositive Net Change HLLYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Agilon (AGL) delivered earnings and revenue surprises of -127.27% and -4.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AGLPositive Net Change PGNYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank